Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- Check2 days agoChange DetectedUpdates the footer’s Technical “Revision” version indicator from v3.5.2 to v3.5.3 without changing the study details displayed on the page.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedMelanoma and related topics (MedlinePlus Genetics) were added, and revision updated to v3.5.0 (removing v3.4.3).SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows Revision: v3.4.3. Related topics such as Melanoma and MedlinePlus Genetics were removed, and Revision: v3.4.2 was deleted.SummaryDifference0.2%

- Check67 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics to the Related Topics section; no deletions observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check74 days agoChange DetectedRevision: v3.4.2 is shown as the system revision label, and the government funding operating-status notice has been removed. There are no changes to trial content, eligibility criteria, locations, or study outcomes.SummaryDifference0.4%

Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.